Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

被引:276
|
作者
Khunti, Kamlesh [1 ,2 ]
Davies, Melanie [1 ,2 ]
Majeed, Azeem [3 ]
Thorsted, Brian Larsen [4 ]
Wolden, Michael Lyng [4 ]
Paul, Sanjoy K. [5 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester, Leics, England
[2] Univ Leicester, Leicester Clin Trials Unit, Leicester, Leics, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England
[4] Novo Nordisk AS, Bagsvaerd, Denmark
[5] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
关键词
GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; VETERANS; EVENTS;
D O I
10.2337/dc14-0920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEHypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.RESEARCH DESIGN AND METHODSThis retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (30 years of age) with a diagnosis of diabetes.RESULTSIn patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.CONCLUSIONSHypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [1] Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes
    Cha, Seon-Ah
    Yun, Jae-Seung
    Lim, Tae-Seok
    Hwang, Seawon
    Yim, Eun-Jung
    Song, Ki-Ho
    Yoo, Ki-Dong
    Park, Yong-Moon
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 202 - 210
  • [2] Relationship between HbA1c and all-cause mortality in older patients with insulin-treated type 2 diabetes: results of a large UK Cohort Study
    Anyanwagu, Uchenna
    Mamza, Jil
    Donnelly, Richard
    Idris, Iskandar
    AGE AND AGEING, 2019, 48 (02) : 235 - 240
  • [3] Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study
    Raffield, Laura M.
    Hsu, Fang-Chi
    Cox, Amanda J.
    Carr, J. Jeffrey
    Freedman, Barry I.
    Bowden, Donald W.
    DIABETOLOGY & METABOLIC SYNDROME, 2015, 7
  • [4] Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study
    Lu, Jingyi
    Wang, Chunfang
    Shen, Yun
    Chen, Lei
    Zhang, Lei
    Cai, Jinghao
    Lu, Wei
    Zhu, Wei
    Hu, Gang
    Xia, Tian
    Zhou, Jian
    DIABETES CARE, 2021, 44 (02) : 549 - 555
  • [5] Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study
    Boureau, Anne-Sophie
    Guyomarch, Beatrice
    Gourdy, Pierre
    Allix, Ingrid
    Annweiler, Cedric
    Cervantes, Nathalie
    Chapelet, Guillaume
    Delabriere, Isabelle
    Guyonnet, Sophie
    Litke, Rachel
    Paccalin, Marc
    Penfornis, Alfred
    Saulnier, Pierre-Jean
    Wargny, Matthieu
    Hadjadj, Samy
    de Decker, Laure
    Cariou, Bertrand
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (07) : 2107 - 2119
  • [6] Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: an observational, register-based cohort study
    Avdic, Tarik
    Carlsen, Hanne K.
    Rawshani, Aidin
    Gudbjornsdottir, Soffia
    Mandalenakis, Zacharias
    Eliasson, Bjorn
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [7] Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
    Pacilli, Antonio
    Lamacchia, Olga
    Fontana, Andrea
    Copetti, Massimiliano
    Cignarelli, Mauro
    Trischitta, Vincenzo
    De Cosmo, Salvatore
    PLOS ONE, 2015, 10 (04):
  • [8] Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
    Gamble, J. -M.
    Simpson, S. H.
    Eurich, D. T.
    Majumdar, S. R.
    Johnson, J. A.
    DIABETES OBESITY & METABOLISM, 2010, 12 (01) : 47 - 53
  • [9] Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis
    Sun, Rui
    Wang, Jianxin
    Li, Meng
    Li, Jingen
    Pan, Yi
    Liu, Birong
    Lip, Gregory Y. H.
    Zhang, Lijing
    DIABETES CARE, 2024, 47 (12) : 2266 - 2274
  • [10] A Population-Based Study of All-Cause Mortality and Cardiovascular Disease in Association With Prior History of Hypoglycemia Among Patients With Type 1 Diabetes
    Lu, Chin-Li
    Shen, Hsiu-Nien
    Hu, Susan C.
    Wang, Jung-Der
    Li, Chung-Yi
    DIABETES CARE, 2016, 39 (09) : 1571 - 1578